AETHLON MEDICAL, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AETHLON MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $1.82M.
- AETHLON MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $3.54M, a 225.92% increase year-over-year.
- AETHLON MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $186.50K.
- AETHLON MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $1.09M, a 75.34% increase year-over-year.
- AETHLON MEDICAL, INC. stock issued during period, value, new issues for fiscal 2026 was $3.74M, a 5.78% increase from fiscal 2025.
- AETHLON MEDICAL, INC. stock issued during period, value, new issues for fiscal 2025 was $3.54M, a 167.69% increase from fiscal 2024.
- AETHLON MEDICAL, INC. stock issued during period, value, new issues for fiscal 2024 was $1.32M, a 85.19% decline from fiscal 2023.
- AETHLON MEDICAL, INC. stock issued during period, value, new issues for fiscal 2023 was $8.93M, a 80.43% increase from fiscal 2022.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $1.82M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.74M 10-K · filed 2026-06-10 | |
| 2025-03-31 | $3.54M 10-K · filed 2026-06-10 | |
| 2024-06-30 | $3.54M 10-Q · filed 2026-02-12 | |
| 2024-03-31 | $1.32M 10-K · filed 2025-06-26 | |
| 2023-12-31 | $186.50K 10-Q · filed 2025-02-12 | |
| 2023-06-30 | $1.09M 10-Q · filed 2025-02-12 | |
| 2023-03-31 | $8.93M 10-K · filed 2024-06-27 | |
| 2022-09-30 | $8.31M 10-Q · filed 2024-02-14 | |
| 2022-06-30 | $619.44K 10-Q · filed 2024-02-14 | |
| 2022-03-31 | $4.95M 10-K · filed 2023-06-28 | |
| 2021-06-30 | $4.95M 10-Q · filed 2023-02-13 | |
| 2021-03-31 | $7.26M 10-K · filed 2022-06-28 | |
| 2020-06-30 | $7.26M 10-Q · filed 2022-02-14 | |
| 2020-03-31 | $896.03K 10-K · filed 2021-06-24 | |
| 2019-09-30 | $386.61K 10-Q · filed 2021-02-10 | |
| 2019-06-30 | $36.62K 10-Q · filed 2021-02-10 | |
| 2019-03-31 | $1.05M 10-K · filed 2020-06-25 | |
| 2018-03-31 | $2.10M 10-K · filed 2019-07-01 | |
| 2017-03-31 | $955.11K 10-K · filed 2018-06-08 | |
| 2016-03-31 | $5.61M 10-K · filed 2017-06-28 | |
| 2015-03-31 | $4.76M 10-K · filed 2016-06-29 | |
| 2014-03-31 | $1.68M 10-K · filed 2015-07-13 | |
| 2013-03-31 | $2.11M 10-K · filed 2014-07-15 | |
| 2012-03-31 | $300.00K 10-K · filed 2013-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |